What are the treatment options for Raynaud's disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Treatment options for Raynaud's disease should prioritize lifestyle modifications and calcium channel blockers, such as nifedipine, as the first-line approach to reduce the frequency and severity of attacks and improve quality of life. According to the most recent evidence from 2023, published in the Nature Reviews Rheumatology 1, lifestyle changes are crucial in managing Raynaud's disease, including avoiding triggers like cold exposure, stress, and smoking, as well as wearing proper clothing in cold conditions. Some key lifestyle modifications include:

  • Keeping the whole body warm
  • Wearing gloves or mittens in cold environments
  • Avoiding triggers like cold exposure and stress
  • Stopping smoking
  • Limiting caffeine intake
  • Exercising regularly to improve circulation For medication options, nifedipine (10-30 mg daily) is the most commonly prescribed calcium channel blocker to relax blood vessels and improve blood flow 1. Other medications that may be considered include:
  • Alpha-blockers such as prazosin (1-5 mg twice daily)
  • Vasodilators like sildenafil (20 mg three times daily)
  • Topical nitroglycerin applied to affected areas In severe cases unresponsive to medications, procedures such as sympathectomy (surgical cutting of nerves) or botulinum toxin injections may be considered 1. The choice of treatment depends on symptom severity, with the goal being to reduce the frequency and severity of attacks, improve quality of life, and prevent tissue damage. Most people with primary Raynaud's can manage their condition with lifestyle changes alone, while secondary Raynaud's often requires medication. It is essential to note that the treatment of Raynaud's disease should be individualized, and the patient's specific needs and circumstances should be taken into account when making treatment decisions 1.

From the Research

Treatment Options for Raynaud's Disease

  • The primary treatment for Raynaud's disease includes avoiding triggers such as cold temperatures and stress, as well as lifestyle changes like quitting smoking and exercising regularly 2.
  • Medications may be prescribed to help manage symptoms, including:
    • Calcium channel blockers, which can help reduce the frequency and severity of attacks by promoting vasodilation 3, 4, 5.
    • Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs), which may provide some minor benefits in relieving symptoms, although more research is needed to confirm their effectiveness 6.
    • Other medications such as alpha-adrenergic blockers, pentoxifylline, dipyridamole, and low-dose acetylsalicylic acid may also be used to treat Raynaud's disease 2.

Effectiveness of Treatment Options

  • Calcium channel blockers have been shown to be effective in reducing the frequency and severity of attacks, with a moderate quality of evidence 5.
  • ACE inhibitors and ARBs may provide some benefits, but the evidence is limited and more research is needed to confirm their effectiveness 6.
  • Lifestyle changes and behavioral therapies, such as stress management and relaxation training, can also be effective in managing symptoms 2.

Side Effects and Risks

  • Calcium channel blockers can cause side effects such as headaches, dizziness, and ankle edema, but are generally well-tolerated 3, 5.
  • ACE inhibitors and ARBs may cause side effects such as cough, dizziness, and increased potassium levels, but are generally considered safe 6.
  • It is essential to discuss the potential risks and benefits of each treatment option with a healthcare provider to determine the best course of treatment for individual cases of Raynaud's disease.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Managing Raynaud's phenomenon: a practical approach.

American family physician, 1993

Research

Calcium channel blockers for primary Raynaud's phenomenon.

The Cochrane database of systematic reviews, 2014

Research

Calcium channel blockers for primary and secondary Raynaud's phenomenon.

The Cochrane database of systematic reviews, 2017

Research

Renin-angiotensin system mediators and Raynaud's phenomenon.

The Annals of pharmacotherapy, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.